SARS-CoV-2-IN-15 [1580-42-3]

TargetMol Chemicals

SARS-CoV-2-IN-15 [1580-42-3]

72

Chemical

Research Use Only

SARS-CoV-2-IN-15

C14H9ClF3NO2

315.67

SARS-CoV-2-IN-15 (compound 11) is a niclosamide analogue exhibiting greater stability in human plasma and liver S9 enzyme assays compared to niclosamide. It enhances bioavailability and half-life upon oral administration and is a potent SARS-CoV-2 inhibitor with an IC50 of 0.49 microM [1].

3 years

OC1=CC=C(Cl)C=C1C(=O)NC1=CC=CC(=C1)C(F)(F)F

-20°C

51202000